The ATP5PD gene helps mitochondria, the parts of cells that make energy, produce ATP, which is the body’s main fuel. In medicine, this gene is important because it helps regulate how cells meet energy needs, especially in the brain, muscles, and heart. If the ATP5PD gene does not work properly, cells may not make enough energy. Pathogenic variants in this gene are linked to a rare inherited mitochondrial condition that can cause low muscle tone, developmental delay, feeding problems, and lactic acidosis (too much acid in the blood).
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes carry the information needed to make proteins, the working parts of cells. Others mainly help direct when certain processes happen, where they take place, and how active they are. Together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ATP5PDGene function
What if the gene works
The ATP5PD gene helps mitochondria make ATP, the cell’s main energy source. It provides part of ATP synthase, a protein complex that uses energy from food and oxygen to power everyday cell activities.
Risk
What if the gene does not work
Disruptive variants in the ATP5PD gene can reduce cellular energy production by weakening the cell's energy system. People may develop low muscle tone, developmental delay, lactic acid buildup, and heart or liver problems, while milder variants may cause milder symptoms.
Treatment
What does that mean for your treatment
At present, no treatment or drug selection approach linked specifically to a pathogenic variant in the ATP5PD gene is established. Care is based on the person’s symptoms and overall mitochondrial disease features rather than on a gene guided medication choice.
Gene function
What if the gene works
Every heartbeat, muscle movement, and nerve signal depends on a steady supply of cellular energy. The ATP5PD gene helps mitochondria, the parts of cells that make most ATP, support that supply. When it works normally, it contributes to the protein machinery that turns energy from food and oxygen into ATP, the cell’s main fuel.
The ATP5PD gene helps mitochondria make ATP, the small molecule cells use as their main energy source. This supports everyday work such as muscle movement, nerve signaling, and heart function.
Its protein forms part of ATP synthase, the enzyme that produces ATP inside mitochondria. It helps keep this energy making machine stable while other parts move during ATP production.
This protein helps ATP synthase turn a proton gradient (a built up difference in tiny charged particles across the inner mitochondrial membrane) into usable cell energy. That is a core part of how the ATP5PD gene helps cells make energy efficiently.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental factors. Many do not have any noticeable effect and are part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants influence the ATP5PD gene's function starts with their effect on a key part of the cell's machinery for making energy in mitochondria (the cell's energy centers). Some variants make the ATP5PD protein unstable or alter its shape, so it cannot join the larger ATP synthase complex properly, which lowers energy production. Milder variants may leave some activity, while more severe variants can greatly reduce complex V assembly and are often linked to earlier and pronounced mitochondrial disease.
How variants are linked to conditions
The ATP5PD gene does not yet have a broadly confirmed link to a specific health condition, although research on ATP5PD gene variants linked to conditions is still developing. If you carry a reported change in the ATP5PD gene, the meaning of that result is best interpreted with your doctor or a genetic counselor in the context of your symptoms, family history, and other test findings.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one specific, well-understood variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ATP5PD gene. Anyone with concerns about personal or family risk can speak with a doctor or genetic counselor for advice based on their own history.
Inheritance of ATP5PD variants
For families looking into how ATP5PD variants are passed down, the ATP5PD inheritance pattern is autosomal recessive. This means a person usually develops an ATP5PD-related condition only when they inherit one disease-causing variant from each parent. Parents who each carry one variant are typically unaffected carriers, and in each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without either familial variant. Sons and daughters are affected at similar rates.
What does my ATP5PD result mean for my family?
For ATP5PD, the related condition is passed down in a recessive way. This usually means parents can be healthy carriers, while brothers or sisters may also be affected or may carry the same gene change without symptoms. Other relatives on both sides of the family may also be carriers, which can matter for family planning.
Genetic information
Genetic testing
How you find out about variants
ATP5PD variants are usually found through genetic testing for ATP5PD variants as part of a multigene panel, whole exome sequencing, or whole genome sequencing. The test uses a blood sample or cheek swab to read the ATP5PD gene’s DNA code and look for changes. Results can show whether a variant is present and whether it is linked to disease.
When should I consider getting a genetic test?
Genetic testing may be worth discussing if someone has unexplained signs of a mitochondrial energy condition, such as developmental delay, muscle weakness, seizures, or high lactic acid levels in the blood, especially if similar problems run in the family. ATP5PD is usually checked as part of a broader gene panel rather than on its own.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies based on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clearer answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment may work well for one person, cause more side effects in another, or have less effect in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape the way a person responds to medication. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes affect either how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. To explore this subject further, you can read more in the LearnHub.
Drugs influenced by the ATP5PD gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how your medicines may be affecting you are best discussed with your doctor.
History
ATP5PD entered the genetics literature through work on the mitochondrial ATP synthase complex, a major focus of cell biology in the late 20th century. Initially understood through studies of the protein complex itself, it was later linked to a specific human gene as sequencing methods improved. Scientific classifications changed as researchers learned more about the gene. Over time, its naming also became more standardized, and ATP5PD replaced older labels used in earlier papers. From these first observations, research expanded steadily. More recent clinical reports connected rare ATP5PD variants with human disease, bringing the gene from basic laboratory research into medical genetics.